LHFPL1 activators exert their influence through a variety of intricate cellular mechanisms, each converging on the common endpoint of enhancing the protein's functional activity. For instance, the modulation of second messenger systems plays a pivotal role in the activation of LHFPL1. Certain small molecules can elevate intracellular cyclic AMP (cAMP) levels, which in turn activates protein kinase A. This kinase is known to phosphorylate a wide array of target proteins, and phosphorylation is a post-translational modification that has the potential to increase the activity of LHFPL1. In a similar vein, compounds that induce alterations in intracellular calcium levels can activate calcium-dependent enzymes, which are capable of modifying proteins in a way that leads to an upregulation of LHFPL1 activity. Furthermore, the utilization of specific ion channel modulators influences ion fluxes, thus altering cellular signaling cascades that can culminate in the positive modulation of LHFPL1.
Another layer of regulation is introduced through the interaction of LHFPL1 with different enzymatic pathways, further diversifying the means by which its activity can be amplified. For example, the inhibition of phosphodiesterase results in the sustained presence of cAMP within the cell, indirectly leading to a cascade of events that promote the activation of LHFPL1. Additionally, there are lipid molecules that, upon binding to their cognate receptors, instigate a series of phosphorylation events that can ultimately enhance the function of LHFPL1. The strategic inhibition of specific kinases also plays a paradoxical role, where the inhibition of one kinase may trigger a compensatory response, increasing the activity of another kinase that acts upon LHFPL1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating intracellular cAMP levels, forskolin activates protein kinase A (PKA), which can phosphorylate various proteins, including LHFPL1, leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a diacylglycerol analog, PMA activates protein kinase C (PKC), which can then phosphorylate target proteins. PKC-mediated phosphorylation can enhance the activity of LHFPL1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent enzymes that could modify the function or localization of LHFPL1, thus enhancing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that increases cAMP levels, leading to activation of PKA. PKA can then phosphorylate LHFPL1, resulting in its activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective phosphodiesterase inhibitor that prevents cAMP degradation, thereby indirectly increasing PKA activity which may lead to the phosphorylation and activation of LHFPL1. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
This cardiac glycoside inhibits Na+/K+-ATPase, leading to alterations in ion gradients and secondary activation of signaling cascades that could result in the activation of LHFPL1. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
This compound activates transient receptor potential vanilloid 1 (TRPV1) channels, which influences calcium influx and could modulate signaling pathways that activate LHFPL1. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
A potent PKA inhibitor that can lead to compensatory mechanisms within cells, potentially resulting in the overactivation of other kinases that could phosphorylate and activate LHFPL1. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Can initiate signaling cascades through its receptors that might include phosphorylation events, indirectly leading to the activation of LHFPL1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This polyphenolic compound activates sirtuin 1 (SIRT1), which can influence various signaling pathways and may have downstream effects on the activation state of LHFPL1. | ||||||